At a glance
ClinicalIndex Comparison RecordN/ACompleted· 217 enrolled
Drug / intervention
CSPS toothpaste +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An 8-Week, Randomized, Controlled, Examiner-Blind, Clinical Study to Evaluate the Efficacy of a Calcium Sodium Phosphosilicate Toothpaste for the Relief of Dentin Hypersensitivity in a Population of Dentin Hypersensitivity Sufferers
In Brief
A clinical study evaluating CSPS toothpaste and Regular fluoride toothpaste (Crest Cavity Protection) for Dentin Sensitivity. Completed, enrolled 217 participants across 1 site.
Detailed Summary
The aim of this study is to confirm the clinical dentin hypersensitivity (DH) efficacy of a 5 percent (%) calcium sodium phosphosilicate (CSPS) toothpaste.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentin Sensitivity
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
20252026
Enrollment StartApr 2024
First PostedApr 2024
Primary CompletionSep 2024
TodayJul 2026
First PostedApr 22, 2024
Enrollment StartApr 16, 2024
Primary CompletionSep 4, 2024
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 2.2 years ago
Interventions
CSPS toothpastedrug
Toothpaste containing 5.0% weight/weight (w/w) CSPS.
Regular fluoride toothpaste (Crest Cavity Protection)drug
Regular fluoride toothpaste containing 1100 parts per million (ppm) fluoride.